These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1376493)

  • 1. Soluble interleukin-2 receptors in children with juvenile chronic arthritis.
    Fassbender K; Michels H; Vogt P; Aeschlimann A; Müller W
    Scand J Rheumatol; 1992; 21(3):120-3. PubMed ID: 1376493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated soluble CD8 antigen and soluble interleukin-2 receptors in the sera of patients with juvenile rheumatoid arthritis.
    Lipnick RN; Sfikakis PP; Klipple GL; Tsokos GC
    Clin Immunol Immunopathol; 1993 Jul; 68(1):64-7. PubMed ID: 8513595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum interleukin-6 levels and joint involvement in polyarticular and pauciarticular juvenile chronic arthritis.
    De Benedetti F; Robbioni P; Massa M; Viola S; Albani S; Martini A
    Clin Exp Rheumatol; 1992; 10(5):493-8. PubMed ID: 1458703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphokines and soluble interleukin-2 receptors in juvenile chronic arthritis. Clinical and laboratory correlations.
    Müller K; Pedersen FK; Wiik A; Bendtzen K
    Rheumatol Int; 1992; 12(3):89-92. PubMed ID: 1411093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum cytokines in juvenile rheumatoid arthritis. Correlation with conventional inflammation parameters and clinical subtypes.
    Mangge H; Kenzian H; Gallistl S; Neuwirth G; Liebmann P; Kaulfersch W; Beaufort F; Muntean W; Schauenstein K
    Arthritis Rheum; 1995 Feb; 38(2):211-20. PubMed ID: 7848311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased circulating nerve growth factor is directly correlated with disease activity in juvenile chronic arthritis.
    Falcini F; Matucci Cerinic M; Lombardi A; Generini S; Pignone A; Tirassa P; Ermini M; Lepore L; Partsch G; Aloe L
    Ann Rheum Dis; 1996 Oct; 55(10):745-8. PubMed ID: 8984940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum p55 and p75 tumour necrosis factor receptors as markers of disease activity in juvenile chronic arthritis.
    Gattorno M; Picco P; Buoncompagni A; Stalla F; Facchetti P; Sormani MP; Pistoia V
    Ann Rheum Dis; 1996 Apr; 55(4):243-7. PubMed ID: 8733441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine levels in serum and synovial fluid of patients with juvenile rheumatoid arthritis.
    Madson KL; Moore TL; Lawrence JM; Osborn TG
    J Rheumatol; 1994 Dec; 21(12):2359-63. PubMed ID: 7699643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble interleukin-2 receptor in juvenile rheumatoid arthritis.
    Silverman ED; Laxer RM; Nelson DL; Rubin LA
    J Rheumatol; 1991 Sep; 18(9):1398-402. PubMed ID: 1757944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interleukin-6 (IL-6), soluble interleukin-2-receptor (sIL-2R) and microheterogeneity of alpha-! acid glycoprotein (AGP): new markers of the acute-phase reaction?].
    Karrer U; Aeschlimann A; Fassbender K; Vogt P; Müller W
    Schweiz Med Wochenschr; 1992 Feb; 122(7):233-6. PubMed ID: 1539125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin E-rheumatoid factor in juvenile rheumatoid arthritis.
    Ferreira RA; Ferriani VP; Sopelete MC; Silva DA; Mineo JR; Kiss MH; Silva CH
    Rev Hosp Clin Fac Med Sao Paulo; 2002; 57(5):209-16. PubMed ID: 12436177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum concentrations of soluble interleukin 2 receptor in patients with rheumatoid arthritis: effect of second line drugs.
    Crilly A; Madhok R; Watson J; Capell HA
    Ann Rheum Dis; 1993 Jan; 52(1):58-60. PubMed ID: 8093995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-1 receptor antagonist in neonates, children and adults, and in patients with pauci- and polyarticular onset juvenile chronic arthritis.
    Müller K; Zak M; Nielsen S; Pedersen FK; de Nully P; Bendtzen K
    Clin Exp Rheumatol; 1997; 15(4):439-44. PubMed ID: 9272308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of reduced serum cartilage oligomeric matrix protein levels in systemic juvenile idiopathic arthritis patients treated with the anti-interleukin-6 receptor monoclonal antibody tocilizumab.
    Nakajima S; Naruto T; Miyamae T; Imagawa T; Mori M; Nishimaki S; Yokota S
    Mod Rheumatol; 2009; 19(1):42-6. PubMed ID: 18726067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma and synovial fluid soluble CD23 concentrations in children with juvenile chronic arthritis.
    Kutukculer N; Caglayan S
    Autoimmunity; 1998; 27(3):155-8. PubMed ID: 9609133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-18 as a mediator of systemic juvenile idiopathic arthritis.
    Jelusić M; Lukić IK; Tambić-Bukovac L; Dubravcić K; Malcić I; Rudan I; Batinić D
    Clin Rheumatol; 2007 Aug; 26(8):1332-4. PubMed ID: 17597334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and laboratory parameters which affect soluble interleukin-2 receptor levels in the serum and synovial fluids of patients with rheumatoid arthritis.
    Matsumoto T; Iwasaki K
    Ann Rheum Dis; 1993 Dec; 52(12):876-80. PubMed ID: 8311539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-6 and soluble interleukin-2 receptor in juvenile chronic arthritis: correlations with clinical and laboratory parameters.
    Spadaro A; Riccieri V; Sili Scavalli A; Sensi F; Fiore D; Taccari E; Zoppini A
    Rev Rhum Engl Ed; 1996 Mar; 63(3):171-7. PubMed ID: 8731234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating interleukin-6, soluble interleukin-2 receptors, tumor necrosis factor alpha, and interleukin-10 levels in juvenile chronic arthritis: correlations with soft tissue vascularity assessed by power Doppler sonography.
    Shahin AA; Shaker OG; Kamal N; Hafez HA; Gaber W; Shahin HA
    Rheumatol Int; 2002 Jun; 22(2):84-8. PubMed ID: 12070682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of hyaluronic acid indicate the severity of joint symptoms in patients with systemic and polyarticular juvenile rheumatoid arthritis.
    Takei S; Imanaka H; Maeno N; Shigemori M; Masuda K; Hokonohara M; Miyata K
    J Rheumatol; 1996 Nov; 23(11):1956-62. PubMed ID: 8923375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.